Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Stanford University
Stanford University
Cyteir Therapeutics, Inc.
Immodulon Therapeutics Ltd
OHSU Knight Cancer Institute
Genzada Pharmaceuticals USA, Inc.
NYU Langone Health